Evidence map›Paper›PMID 33230715›Full record

ArticleMolecular neurobiology2021

Exposure of the SH-SY5Y Human Neuroblastoma Cells to 50-Hz Magnetic Field: Comparison Between Two-Dimensional (2D) and Three-Dimensional (3D) In Vitro Cultures.

Claudia Consales, Alessio Butera, Caterina Merla, Emanuela Pasquali, Vanni Lopresto, Rosanna Pinto, Maria Pierdomenico, Mariateresa Mancuso, Carmela Marino, Barbara Benassi

Open access · hybridAbstract readComparative Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecular neurobiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.4field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Claudia ConsalesDivision of Health Protection Technologies, ENEA-Casaccia Italian National Agency for New Technologies, Energy and Sustainable Economic Development, Via Anguillarese 301, 00123, Rome, Italy.ORCID https://orcid.org/0000-0002-7805-4493
Alessio ButeraExperimental Medicine and Surgery, University of Rome Tor Vergata, 00133, Rome, Italy.ORCID https://orcid.org/0000-0001-7196-4235
Caterina MerlaDivision of Health Protection Technologies, ENEA-Casaccia Italian National Agency for New Technologies, Energy and Sustainable Economic Development, Via Anguillarese 301, 00123, Rome, Italy.ORCID https://orcid.org/0000-0001-8612-9566
Emanuela PasqualiDivision of Health Protection Technologies, ENEA-Casaccia Italian National Agency for New Technologies, Energy and Sustainable Economic Development, Via Anguillarese 301, 00123, Rome, Italy.ORCID https://orcid.org/0000-0002-3997-0659
Vanni LoprestoDivision of Health Protection Technologies, ENEA-Casaccia Italian National Agency for New Technologies, Energy and Sustainable Economic Development, Via Anguillarese 301, 00123, Rome, Italy.ORCID https://orcid.org/0000-0002-9517-6994
Rosanna PintoDivision of Health Protection Technologies, ENEA-Casaccia Italian National Agency for New Technologies, Energy and Sustainable Economic Development, Via Anguillarese 301, 00123, Rome, Italy.ORCID https://orcid.org/0000-0002-9052-9797
Maria PierdomenicoDivision of Health Protection Technologies, ENEA-Casaccia Italian National Agency for New Technologies, Energy and Sustainable Economic Development, Via Anguillarese 301, 00123, Rome, Italy.ORCID https://orcid.org/0000-0002-0749-7609
Mariateresa MancusoDivision of Health Protection Technologies, ENEA-Casaccia Italian National Agency for New Technologies, Energy and Sustainable Economic Development, Via Anguillarese 301, 00123, Rome, Italy.ORCID https://orcid.org/0000-0002-0912-9287
Carmela MarinoDivision of Health Protection Technologies, ENEA-Casaccia Italian National Agency for New Technologies, Energy and Sustainable Economic Development, Via Anguillarese 301, 00123, Rome, Italy.ORCID https://orcid.org/0000-0002-8782-1922
Barbara BenassiDivision of Health Protection Technologies, ENEA-Casaccia Italian National Agency for New Technologies, Energy and Sustainable Economic Development, Via Anguillarese 301, 00123, Rome, Italy. barbara.benassi@enea.it.
National Agency for New Technologies, Energy and Sustainable Economic Development · ITUniversity of Rome Tor Vergata · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We here characterize the response to the extremely low-frequency (ELF) magnetic field (MF, 50 Hz, 1 mT) of SH-SY5Y human neuroblastoma cells, cultured in a three-dimensional (3D) Alvetex

Indexed as

Cell Culture TechniquesMagnetic FieldsApoptosisBiomarkersCell DifferentiationCell Line, TumorCell ProliferationDopaminergic NeuronsGlutathioneHumansMicroRNAsNeovascularization, PhysiologicNeuroblastomaPhenotypeRNA, MessengerSuperoxide Dismutase-1BiomarkersGlutathioneMicroRNAsRNA, MessengerSuperoxide Dismutase-13D cultureExtremely low-frequency magnetic fieldIn vitroMicroRNAsSH-SY5Y

Identifiers

PMID33230715
PMCPMC7932966
OpenAlexW3109789350

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.